We recently received an interesting question from one of our readers. “If oral therapy is not effective and in less than a year of diagnosis I am already moving to inhaled, does this mean I will not have a chance at survival like a patient who does well with the initial pills?” … [Read more...]
Handicap Placard for PH patients
Pulmonary arterial hypertension is a rare and debilitating disease that affects the blood vessels of the lungs. Many PH patients experience fatigue and shortness of breath with activity. These patients would benefit from having a disability placard on their vehicle. … [Read more...]
Winter Weather Causes Shipping Delays For PAH Medications
The United States is getting hit with brutal severe winter weather this year and the country held their breath when UPS and FedEx stated that they could not fulfill their Christmas shipping deadlines. These delays affect the specialty pharmacies shipping directly to pulmonary arterial hypertension patients as well as suppliers shipping to your local pharmacies. … [Read more...]
5 Resolutions for the New Year
The ball has dropped and the new year has begun. This is a great opportunity for pulmonary hypertension patients, their caregivers, or anyone with a chronic disease to vow to improve their health this year. Below are 5 simple resolutions that may help make 2014 a healthier happier year. … [Read more...]
Oral trepsostinil (Remodulin) approved by FDA
After more than seven years of development and clinical trials, United Therapeutics received approval from the FDA on 12/20/2013 for their oral version of treprostinil (Remodulin). The new drug will be called Orenitram. … [Read more...]
